These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1980130)

  • 1. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
    Bakshi R; Newman AH; Faden AI
    J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI
    Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
    Bakshi R; Ni RX; Faden AI
    Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
    Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptor mechanism of dynorphin A in rat secondary spinal cord injuries].
    Li M; Yang Y; Hong X
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):290-3. PubMed ID: 8758278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous opioids in spinal cord injury: a critical evaluation.
    Long JB; Martinez-Arizala A; Petras JM; Holaday JW
    Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
    Song ZH; Takemori AE
    Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism.
    Faden AI
    J Neurosci; 1992 Feb; 12(2):425-9. PubMed ID: 1346803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist.
    Sander HW; Portoghese PS; Gintzler AR
    Brain Res; 1988 Dec; 474(2):343-7. PubMed ID: 2850091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
    Faden AI; Sacksen I; Noble LJ
    J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
    Rady JJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity.
    Skilling SR; Sun X; Kurtz HJ; Larson AA
    Brain Res; 1992 Mar; 575(2):272-8. PubMed ID: 1349253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.